1. Home
  2. BGFV vs RNTX Comparison

BGFV vs RNTX Comparison

Compare BGFV & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGFV
  • RNTX
  • Stock Information
  • Founded
  • BGFV 1955
  • RNTX 2001
  • Country
  • BGFV United States
  • RNTX United States
  • Employees
  • BGFV N/A
  • RNTX N/A
  • Industry
  • BGFV Other Specialty Stores
  • RNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGFV Consumer Discretionary
  • RNTX Health Care
  • Exchange
  • BGFV Nasdaq
  • RNTX Nasdaq
  • Market Cap
  • BGFV 32.5M
  • RNTX 26.5M
  • IPO Year
  • BGFV N/A
  • RNTX N/A
  • Fundamental
  • Price
  • BGFV $1.42
  • RNTX $1.14
  • Analyst Decision
  • BGFV
  • RNTX Hold
  • Analyst Count
  • BGFV 0
  • RNTX 1
  • Target Price
  • BGFV N/A
  • RNTX N/A
  • AVG Volume (30 Days)
  • BGFV 104.1K
  • RNTX 126.4K
  • Earning Date
  • BGFV 10-28-2025
  • RNTX 08-14-2025
  • Dividend Yield
  • BGFV N/A
  • RNTX N/A
  • EPS Growth
  • BGFV N/A
  • RNTX N/A
  • EPS
  • BGFV N/A
  • RNTX N/A
  • Revenue
  • BGFV $762,758,000.00
  • RNTX N/A
  • Revenue This Year
  • BGFV N/A
  • RNTX N/A
  • Revenue Next Year
  • BGFV N/A
  • RNTX N/A
  • P/E Ratio
  • BGFV N/A
  • RNTX N/A
  • Revenue Growth
  • BGFV N/A
  • RNTX N/A
  • 52 Week Low
  • BGFV $0.80
  • RNTX $1.04
  • 52 Week High
  • BGFV $2.45
  • RNTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • BGFV 50.54
  • RNTX 44.23
  • Support Level
  • BGFV $1.19
  • RNTX $1.07
  • Resistance Level
  • BGFV $1.43
  • RNTX $1.43
  • Average True Range (ATR)
  • BGFV 0.01
  • RNTX 0.12
  • MACD
  • BGFV -0.00
  • RNTX -0.00
  • Stochastic Oscillator
  • BGFV 0.00
  • RNTX 18.96

About BGFV Big 5 Sporting Goods Corporation

Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the Western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both its retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: